Veriler yükleniyor…

Public EUDAMED Search

EUDAMED Device Search

A readable public search layer for EUDAMED device, manufacturer, UDI, EMDN and risk class data.

Last updated

01.08.2026 01:12

Sync status

Successful

Device

2988209

Actor

47517

Certificate

3174

Filters

Show filters

Active filter:EMDN:G04

1000+ device results listed.

Page 2 / 50

XLS Medical Pro 7

FAT BINDER FORTE type 1

Class IIbMDR 2017/745On the market

Manufacturer: Omega Pharma International NV
Manufacturer SRN: BE-MF-000007210
UDI-DI: 05400951001180
Basic UDI-DI: 5400951FBFORTIIBT1B3
Reference: CT28088
EMDN: G0402
EMDN description: ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION
First on market country: Italy
Authorised representative: -
Last updated: 31.07.2026 10:49

Manufacturer products View details

XLS Medical Pro 7

FAT BINDER FORTE type 2

Class IIbMDR 2017/745On the market

Manufacturer: Omega Pharma International NV
Manufacturer SRN: BE-MF-000007210
UDI-DI: 05400951001197
Basic UDI-DI: 5400951FBFORTIIBT2B5
Reference: CT28089
EMDN: G0402
EMDN description: ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION
First on market country: Italy
Authorised representative: -
Last updated: 31.07.2026 10:42

Manufacturer products View details

XLS Medical Pro 7 Kapseln

FAT BINDER FORTE type 1

Class IIbMDR 2017/745On the market

Manufacturer: Omega Pharma International NV
Manufacturer SRN: BE-MF-000007210
UDI-DI: 05400951001104
Basic UDI-DI: 5400951FBFORTIIBT1B3
Reference: CT30783
EMDN: G0402
EMDN description: ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION
First on market country: Belgium
Authorised representative: -
Last updated: 31.07.2026 10:42

Manufacturer products View details

EndoSign® Cell collection device

ES-CYT-102

Class IMDR 2017/745On the marketSingle use

Manufacturer: Cyted Ltd
Manufacturer SRN: GB-MF-000035140
UDI-DI: 05061009420010
Basic UDI-DI: 506100942ES-CYT-102Z9
Reference: ES-CYT-102
EMDN: G0499
EMDN description: ORALLY ADMINISTERED GASTROINTESTINAL DEVICES - OTHER
First on market country: Sweden
Authorised representative: Advena Limited
Last updated: 31.07.2026 09:07

Manufacturer products Authorised representative products Authorised representative actors View details

-

Class IIbNot specifiedOn the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778108184
Basic UDI-DI: 42517781MD347D7
Reference: 795089
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: Ireland
Authorised representative: -
Last updated: 31.07.2026 01:07

Manufacturer products View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106234
Basic UDI-DI: 42517781MD339D8
Reference: 1571308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: Germany
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:38

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106241
Basic UDI-DI: 42517781MD339D8
Reference: 1571391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106258
Basic UDI-DI: 42517781MD339D8
Reference: 1571373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106265
Basic UDI-DI: 42517781MD339D8
Reference: 572308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106272
Basic UDI-DI: 42517781MD339D8
Reference: 572391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106289
Basic UDI-DI: 42517781MD339D8
Reference: 572373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106296
Basic UDI-DI: 42517781MD339D8
Reference: 573308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106302
Basic UDI-DI: 42517781MD339D8
Reference: 573391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106319
Basic UDI-DI: 42517781MD339D8
Reference: 573373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106326
Basic UDI-DI: 42517781MD339D8
Reference: 574308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106333
Basic UDI-DI: 42517781MD339D8
Reference: 574391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106340
Basic UDI-DI: 42517781MD339D8
Reference: 574373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106357
Basic UDI-DI: 42517781MD339D8
Reference: 314571308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106364
Basic UDI-DI: 42517781MD339D8
Reference: 314571391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

-

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106371
Basic UDI-DI: 42517781MD339D8
Reference: 314571373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details